Biotechnology is a broad discipline in ... for the controlled expression of therapeutics in engineered oncolytic bacteria, demonstrating significant anti-tumor efficacy in multiple tumor mouse ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

A near-infrared optogenetic system was developed for the controlled expression of therapeutics in engineered oncolytic bacteria ... biology for environmental biotechnology, summarizing their ...

Oncolytics Biotech, Inc. engages in the provision of development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic ...

and only the third oncolytic virus therapy to be made available to patients worldwide, after Shanghai Sunway Biotech's Oncorine for nasopharyngeal carcinoma in 2005 and Amgen's Imlygic (talimogene ...

CG Oncology has taken the ribbon for the first biotech initial public offering ... Cretostimogene grenadenorepvec is an oncolytic virus that is delivered directly into the bladder and is designed ...

Candel Therapeutics has identified a subpopulation of lung cancer patients living longest on its oncolytic virus, leading the biotech to narrow its focus as it heads towards a potentially ...

Here, BiomX is targeting at chronic pulmonary infections caused by Pseudomonas aeruginosa bacteria in cystic fibrosis patients. The nano-cap biotech was trading down 8% premarketing Monday morning.